HUP9900645A3 - Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing - Google Patents

Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing

Info

Publication number: HUP9900645A3
Authority: HU; Hungary
Prior art keywords: producing; pharmaceutical compositions; compositions containing; imidazole compounds; substituted imidazole
Prior art date: 1996-01-11

Application number

HU9900645A

Other languages

English (en)

Hungarian (hu)

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-11

Filing date

1997-01-10

Publication date

2000-03-28

1997-01-10 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1999-06-28 Publication of HUP9900645A2 publication Critical patent/HUP9900645A2/hu

2000-03-28 Publication of HUP9900645A3 publication Critical patent/HUP9900645A3/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Neurology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)

HU9900645A 1996-01-11 1997-01-10 Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing HUP9900645A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US990996P	1996-01-11	1996-01-11

Publications (2)

Publication Number	Publication Date
HUP9900645A2 HUP9900645A2 (hu)	1999-06-28
HUP9900645A3 true HUP9900645A3 (en)	2000-03-28

Family

ID=21740430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9900645A HUP9900645A3 (en)	1996-01-11	1997-01-10	Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing

Country Status (26)

Country	Link
US (3)	US6214844B1 (es)
EP (1)	EP0935465B1 (es)
JP (2)	JP2000503303A (es)
KR (1)	KR19990077165A (es)
CN (1)	CN1213307A (es)
AR (1)	AR006307A1 (es)
AT (1)	ATE264105T1 (es)
AU (1)	AU726084C (es)
BR (1)	BR9706934A (es)
DE (1)	DE69728685T2 (es)
DK (1)	DK0935465T3 (es)
EA (1)	EA001430B1 (es)
ES (1)	ES2219750T3 (es)
HU (1)	HUP9900645A3 (es)
IL (1)	IL125282A (es)
MX (1)	MX9805634A (es)
NO (1)	NO316625B1 (es)
NZ (1)	NZ327052A (es)
OA (1)	OA11514A (es)
PL (1)	PL187616B1 (es)
PT (1)	PT935465E (es)
SK (2)	SK92798A3 (es)
TR (1)	TR199801360T2 (es)
TW (1)	TW523512B (es)
WO (1)	WO1997025046A1 (es)
ZA (1)	ZA97175B (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
AP9700912A0 (en)	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
ZA97175B (en)	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
TR199801361T2 (xx) *	1996-01-11	1998-10-21	Smithkline Beecham Corporation	Yeni ikameli imidazol bile�imleri.
WO1997035856A1 (en) *	1996-03-25	1997-10-02	Smithkline Beecham Corporation	Novel treatment for cns injuries
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US6608060B1 (en) *	1996-12-18	2003-08-19	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5945418A (en) *	1996-12-18	1999-08-31	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
US6087381A (en)	1997-05-22	2000-07-11	G. D. Searle & Company	Pyrazole derivatives as p38 kinase inhibitors
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
US20020156104A1 (en)	1997-06-13	2002-10-24	Jerry L. Adams	Novel pyrazole and pyrazoline substituted compounds
WO1998057966A1 (en)	1997-06-19	1998-12-23	Smithkline Beecham Corporation	Novel aryloxy substituted pyrimidine imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
AU8381098A (en)	1997-07-02	1999-01-25	Smithkline Beecham Corporation	Novel cycloalkyl substituted imidazoles
TW517055B (en)	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
CA2306077A1 (en)	1997-10-08	1999-04-15	Smithkline Beecham Corporation	Novel cycloalkenyl substituted compounds
JP2001526230A (ja)	1997-12-19	2001-12-18	スミスクライン・ビーチャム・コーポレイション	ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
PL344330A1 (en)	1998-05-22	2001-10-22	Smithkline Beecham Corp	Novel 2-alkyl substituted imidazole compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
US6599910B1 (en)	1998-08-20	2003-07-29	Smithkline Beecham Corporation	Substituted triazole compounds
ES2212657T3 (es)	1998-11-04	2004-07-16	Smithkline Beecham Corporation	Pirazinas sustituidas piridin-4-il o pirimidin-4-il.
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
US7122666B2 (en) *	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
ATE281439T1 (de)	1999-11-23	2004-11-15	Smithkline Beecham Corp	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
WO2001038314A1 (en)	1999-11-23	2001-05-31	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
ES2249309T3 (es)	1999-11-23	2006-04-01	Smithkline Beecham Corp	Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
US6759410B1 (en)	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
US7172769B2 (en) *	1999-12-08	2007-02-06	Pharmacia Corporation	Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
US7235551B2 (en) *	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
PE20020146A1 (es) *	2000-07-13	2002-03-31	Upjohn Co	Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
AU5754701A (en) *	2000-07-13	2002-01-30	Pharmacia Corp	Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
NZ524252A (en) *	2000-07-20	2004-03-26	Lauras As	Cox-2 inhibitors for treating HIV and AIDS
AU2002248269A1 (en) *	2000-10-19	2002-08-12	Smithkline Beecham Corporation	Use of p38 inhibitors for the treatment of inflammation-enhanced cough
WO2002059083A2 (en) *	2000-10-23	2002-08-01	Smithkline Beecham Corporation	Novel compounds
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AP2002002463A0 (en) *	2001-03-09	2002-06-30	Pfizer Prod Inc	Novel triazolo-pyrimides anti-inflammatory compounds.
JP2004526727A (ja)	2001-03-09	2004-09-02	ファイザー・プロダクツ・インク	ベンゾイミダゾール抗炎症化合物
MY137736A (en)	2001-04-03	2009-03-31	Pharmacia Corp	Reconstitutable parenteral composition
ES2247271T3 (es) *	2001-04-04	2006-03-01	Pfizer Products Inc.	Nuevos benzotriazoles como compuestos antiinflamatorios.
UA80682C2 (en) *	2001-08-06	2007-10-25	Pharmacia Corp	Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
US20040122008A1 (en) *	2002-09-05	2004-06-24	Protter Andrew A.	Treatment of pain by inhibition of p38 MAP kinase
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US20030225089A1 (en) *	2002-04-10	2003-12-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
EP1534282B1 (en)	2002-07-09	2006-12-27	Boehringer Ingelheim Pharma GmbH & Co.KG	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
US7268139B2 (en)	2002-08-29	2007-09-11	Scios, Inc.	Methods of promoting osteogenesis
US20040092547A1 (en) *	2002-08-30	2004-05-13	Pfizer Inc	Alkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7037923B2 (en) *	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7005523B2 (en) *	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
US6949652B2 (en) *	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US20080039461A1 (en) *	2002-09-05	2008-02-14	Protter Andrew A	Treatment of pain by inhibition of p38 map kinase
UA80296C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Imidazolopyridines and methods of making and using the same
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
CL2004000234A1 (es) *	2003-02-12	2005-04-15	Biogen Idec Inc	Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
MXPA05008568A (es) *	2003-02-14	2005-11-04	Pfizer Prod Inc	Nuevos compuestos anti-inflamatorios triazolo-piridinas.
CL2004000366A1 (es) *	2003-02-26	2005-01-07	Pharmacia Corp Sa Organizada B	USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US7105467B2 (en) *	2003-07-08	2006-09-12	Pharmacore, Inc.	Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
US7244441B2 (en)	2003-09-25	2007-07-17	Scios, Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
US7454007B2 (en) *	2004-03-26	2008-11-18	Samsung Electronics Co., Ltd.	Telecommunication switch using generic API to support multiple protocol-specific signal control functions
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
PE20100737A1 (es)	2005-03-25	2010-11-27	Glaxo Group Ltd	Nuevos compuestos
SG160438A1 (en) *	2005-03-25	2010-04-29	Glaxo Group Ltd	Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5- d]pyrimidin-2(1h)-one derivatives
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8523889B2 (en) *	2007-07-27	2013-09-03	Ethicon Endo-Surgery, Inc.	Ultrasonic end effectors with increased active length
ES2897740T3 (es)	2011-12-28	2022-03-02	Kyoto Prefectural Public Univ Corp	Normalización del cultivo de células endoteliales de la córnea
WO2015072580A1 (ja)	2013-11-14	2015-05-21	学校法人同志社	細胞増殖促進または細胞障害抑制による角膜内皮治療薬
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
EP3691620B1 (en)	2017-10-05	2022-07-27	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US20240165148A1 (en)	2021-03-15	2024-05-23	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3707475A (en) *	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3929807A (en) *	1971-05-10	1975-12-30	Ciba Geigy Corp	2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
US3940486A (en) *	1971-05-10	1976-02-24	Ciba-Geigy Corporation	Imidazole derivatives in the treatment of pain
US4058614A (en) *	1973-12-04	1977-11-15	Merck & Co., Inc.	Substituted imidazole compounds and therapeutic compositions therewith
US4199592A (en) *	1978-08-29	1980-04-22	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl-2-nitroimidazoles
GR75287B (es) *	1980-07-25	1984-07-13	Ciba Geigy Ag
US4503065A (en) *	1982-08-03	1985-03-05	E. I. Du Pont De Nemours And Company	Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
US4565875A (en) *	1984-06-27	1986-01-21	Fmc Corporation	Imidazole plant growth regulators
US4686231A (en) *	1985-12-12	1987-08-11	Smithkline Beckman Corporation	Inhibition of 5-lipoxygenase products
IL83467A0 (en) *	1986-08-15	1988-01-31	Fujisawa Pharmaceutical Co	Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
JPH06504779A (ja) *	1990-12-13	1994-06-02	スミスクライン・ビーチャム・コーポレイション	新規ｃｓａｉｄｓ
ZA919797B (en) *	1990-12-13	1992-10-28	Smithkline Beecham Corp	Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
IL110296A (en) *	1993-07-16	1999-12-31	Smithkline Beecham Corp	Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US5593991A (en) *	1993-07-16	1997-01-14	Adams; Jerry L.	Imidazole compounds, use and process of making
WO1995009847A1 (en) *	1993-10-01	1995-04-13	Ciba-Geigy Ag	Pyrimidineamine derivatives and processes for the preparation thereof
DK0672041T3 (da) *	1993-10-01	2002-02-25	Novartis Ag	Farmakologisk aktive pyridinderivater og fremgangsmåder til fremstilling deraf
US5543520A (en) *	1993-10-01	1996-08-06	Ciba-Geigy Corporation	Pyrimidine derivatives
US5705502A (en) *	1993-10-01	1998-01-06	Novartis Corporation	Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof
HUP0102677A3 (en) *	1995-01-12	2002-09-30	Smithkline Beecham Corp	Trisubstituted imidazole derivatives, process for their preparation and pharmaceutical compositions containing them
US5658903A (en) *	1995-06-07	1997-08-19	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.

1997
- 1997-01-09 ZA ZA9700175A patent/ZA97175B/xx unknown
- 1997-01-10 AR ARP970100104A patent/AR006307A1/es not_active Application Discontinuation
- 1997-01-10 KR KR1019980705303A patent/KR19990077165A/ko not_active Ceased
- 1997-01-10 SK SK927-98A patent/SK92798A3/sk unknown
- 1997-01-10 CN CN97193002A patent/CN1213307A/zh active Pending
- 1997-01-10 SK SK928-98A patent/SK92898A3/sk unknown
- 1997-01-10 IL IL12528297A patent/IL125282A/xx not_active IP Right Cessation
- 1997-01-10 US US09/101,550 patent/US6214844B1/en not_active Expired - Fee Related
- 1997-01-10 WO PCT/US1997/000529 patent/WO1997025046A1/en not_active Ceased
- 1997-01-10 BR BR9706934-5A patent/BR9706934A/pt not_active Application Discontinuation
- 1997-01-10 NZ NZ327052A patent/NZ327052A/xx unknown
- 1997-01-10 PL PL97327934A patent/PL187616B1/pl not_active IP Right Cessation
- 1997-01-10 HU HU9900645A patent/HUP9900645A3/hu not_active Application Discontinuation
- 1997-01-10 US US08/781,466 patent/US5716955A/en not_active Expired - Fee Related
- 1997-01-10 JP JP9525459A patent/JP2000503303A/ja not_active Ceased
- 1997-01-10 AU AU15782/97A patent/AU726084C/en not_active Ceased
- 1997-01-10 TR TR1998/01360T patent/TR199801360T2/xx unknown
- 1997-01-10 ES ES97902013T patent/ES2219750T3/es not_active Expired - Lifetime
- 1997-01-10 DK DK97902013T patent/DK0935465T3/da active
- 1997-01-10 DE DE69728685T patent/DE69728685T2/de not_active Expired - Fee Related
- 1997-01-10 EP EP97902013A patent/EP0935465B1/en not_active Expired - Lifetime
- 1997-01-10 PT PT97902013T patent/PT935465E/pt unknown
- 1997-01-10 AT AT97902013T patent/ATE264105T1/de not_active IP Right Cessation
- 1997-01-10 EA EA199800633A patent/EA001430B1/ru not_active IP Right Cessation
- 1997-08-22 TW TW086112052A patent/TW523512B/zh not_active IP Right Cessation
- 1997-11-21 US US08/976,522 patent/US5811549A/en not_active Expired - Fee Related
1998
- 1998-07-10 MX MX9805634A patent/MX9805634A/es not_active IP Right Cessation
- 1998-07-10 OA OA9800113A patent/OA11514A/en unknown
- 1998-07-10 NO NO19983181A patent/NO316625B1/no not_active IP Right Cessation
2004
- 2004-01-08 JP JP2004003158A patent/JP2004107358A/ja active Pending

Also Published As

Publication number	Publication date
NZ327052A (en)	2000-01-28
KR19990077165A (ko)	1999-10-25
TR199801360T2 (xx)	1998-10-21
AR006307A1 (es)	1999-08-25
ZA97175B (en)	1997-11-04
EP0935465A4 (es)	1999-08-18
PL327934A1 (en)	1999-01-04
EA001430B1 (ru)	2001-02-26
SK92898A3 (en)	1999-05-07
BR9706934A (pt)	2000-10-24
JP2000503303A (ja)	2000-03-21
AU1578297A (en)	1997-08-01
AU726084C (en)	2001-08-30
WO1997025046A1 (en)	1997-07-17
US5716955A (en)	1998-02-10
CN1213307A (zh)	1999-04-07
ES2219750T3 (es)	2004-12-01
TW523512B (en)	2003-03-11
PL187616B1 (pl)	2004-08-31
US5811549A (en)	1998-09-22
SK92798A3 (en)	1999-05-07
HK1022624A1 (en)	2000-08-18
IL125282A (en)	2003-06-24
DE69728685D1 (de)	2004-05-19
HUP9900645A2 (hu)	1999-06-28
DK0935465T3 (da)	2004-08-09
ATE264105T1 (de)	2004-04-15
IL125282A0 (en)	1999-03-12
AU726084B2 (en)	2000-11-02
US6214844B1 (en)	2001-04-10
NO983181L (no)	1998-09-10
EP0935465A1 (en)	1999-08-18
JP2004107358A (ja)	2004-04-08
DE69728685T2 (de)	2005-04-14
EP0935465B1 (en)	2004-04-14
OA11514A (en)	2004-02-04
PT935465E (pt)	2004-08-31
MX9805634A (es)	1998-11-30
EA199800633A1 (ru)	1999-02-25
NO316625B1 (no)	2004-03-15

Publication	Publication Date	Title
HUP9900645A3 (en)	2000-03-28	Novel substituted imidazole compounds, pharmaceutical compositions containing them and process for their producing
HUP0002050A3 (en)	2002-04-29	Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use
HUP9902460A3 (en)	2000-03-28	Novel substituted imidazole compounds, their use, method for their preparation and pharmaceutical compositions containing them
HUP0002842A3 (en)	2002-01-28	Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates
HUP0000068A3 (en)	2001-12-28	Process for producing ecteinascidin compounds, their use and pharmaceutical compositions containing them
HUP9700344A3 (en)	1998-04-28	Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9900625A3 (en)	2003-04-28	Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
HUP9802565A3 (en)	2000-01-28	N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9602511A2 (en)	1997-03-28	Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP9701265A3 (en)	2000-05-29	Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
HUP9601034A3 (en)	1999-03-01	Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
HUP9603433A2 (en)	1997-08-28	4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP9603023A3 (en)	1998-12-28	Substituted (sulfonimidamido)benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602681A1 (en)	1997-09-29	Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en)	2000-06-28	Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9600624A2 (en)	1997-01-28	Fused imidazole derivatives, process for producing them and pharmaceutical compositions containing them
HU9503801D0 (en)	1996-02-28	Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them
HU9701660D0 (en)	1997-12-29	10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, find pharmaceutical compositions containing them
HUP9702341A3 (en)	1999-04-28	New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them
HUP9701921A3 (en)	1999-03-29	Heterocyclic amino-methyl compounds, process for producing them, and pharmaceutical compositions containing them
HU9602640D0 (en)	1996-11-28	Substituted benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602748A3 (en)	1998-04-28	Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
HUP9601976A3 (en)	1998-07-28	4-fluoralkyl benzoylguanidines, process for producing them and pharmaceutical compositions containing these compounds
HUP9702227A3 (en)	1999-03-01	New benzopirane compounds, process for producing them and pharmaceutical composition containing them
HU9503932D0 (en)	1996-03-28	Substituted benzol-sulfonyl-ureas and-thioureas, pharmaceutical compositions containing them and process for producing them

Legal Events

Date	Code	Title	Description
2007-07-30	FC4A	Lapse of provisional application due to refusal